These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 2483433)
1. Inodilators: a new strategy in the therapy of heart failure. Proceedings of a symposium held during the 24th National Congress of the Italian Society for Pharmacology. Brescia, Italy, September 28, 1988. J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S1-132. PubMed ID: 2483433 [No Abstract] [Full Text] [Related]
2. [Myocardial oxygen consumption and relationship to cardiovascular effects of clinical inodilators]. Honerjäger P; Mitrovic V; Schlepper M Med Klin (Munich); 1994 Feb; 89(2):89-94. PubMed ID: 8164602 [No Abstract] [Full Text] [Related]
4. [New inotropic vasodilators: what is their role in the long-term treatment of heart failure?]. Padrini R G Ital Cardiol; 1987 Mar; 17(3):259-63. PubMed ID: 3301506 [No Abstract] [Full Text] [Related]
5. [Treatment of resistant cardiac failure; vasodilators and new inotropic drugs]. Herziano H; Gil I; Almog C Harefuah; 1980 Jun; 98(11-12):517-8. PubMed ID: 7203196 [No Abstract] [Full Text] [Related]
6. [Drug therapy of cardiovascular diseases. Heart failure. Introduction to the subject. Progress since 1982]. Scholz H Z Kardiol; 1992; 81 Suppl 4():15-6. PubMed ID: 1290292 [No Abstract] [Full Text] [Related]
7. Pharmacotherapy of congestive heart failure: pimobendan, a new approach to inotropic stimulation. Proceedings of a satellite symposium to the Xth European Congress of Cardiology. Vienna, Austria, August 31, 1988. J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S1-64. PubMed ID: 2478785 [No Abstract] [Full Text] [Related]
8. Failure of many new heart-failure drugs: the need for vasoconstrictor rather than vasodilator agents? Cleland JG Br J Hosp Med; 1994 Sep 7-20; 52(5):193, 195-6. PubMed ID: 7820314 [No Abstract] [Full Text] [Related]
9. [Pharmacotherapy of severe heart failure with inodilators--new approaches]. Baumann G; Hader O Z Kardiol; 1996; 85 Suppl 4():9-19. PubMed ID: 9027110 [TBL] [Abstract][Full Text] [Related]
10. A symposium: The use of enoximone in heart failure. September 14, 1986, Washington, D.C. Proceedings. Am J Cardiol; 1987 Aug; 60(5):1C-90C. PubMed ID: 2956860 [No Abstract] [Full Text] [Related]
12. [Application of vasodilator and positive inotropic agents in the treatment of heart failure]. Chen SX Zhonghua Yi Xue Za Zhi; 1983 Nov; 63(11):705-8. PubMed ID: 6426739 [No Abstract] [Full Text] [Related]
13. Principles of treatment of left ventricular failure. Taylor SH; Silke B; Nelson GI Eur Heart J; 1982 Dec; 3 Suppl D():19-43. PubMed ID: 6761126 [No Abstract] [Full Text] [Related]
15. Clinical pharmacology of inodilators. Dei Cas L; Metra M; Visioli O J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S60-71. PubMed ID: 2483442 [TBL] [Abstract][Full Text] [Related]
16. [Rational and irrational approach to the inotropic agent therapy of heart failure]. Colombo F; Libretti A Clin Ter; 1988 Sep; 126(6):421-6. PubMed ID: 2974404 [No Abstract] [Full Text] [Related]
17. Vasodilators and inotropic agents in the treatment of congestive heart failure. Francis GS Semin Nephrol; 1994 Sep; 14(5):464-78. PubMed ID: 7997651 [TBL] [Abstract][Full Text] [Related]
18. [Therapy of heart failure]. Comelli AM Clin Ter; 1987 Feb; 120(3):237-46. PubMed ID: 2904316 [No Abstract] [Full Text] [Related]
19. Can new inodilators displace digitalis in the therapy of congestive heart failure? Kumada T; Kawai C Cardiovasc Drugs Ther; 1989 Jan; 2(6):751-5. PubMed ID: 2488088 [TBL] [Abstract][Full Text] [Related]
20. [Vasodilators in cardiac insufficiency]. Bernardi LF; de Nononay NC Arq Bras Cardiol; 1980 Jan; 34(1):53-62. PubMed ID: 7406738 [No Abstract] [Full Text] [Related] [Next] [New Search]